Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla

BACKGROUND: Inhibition of early platelet adhesion by blockade of glycoprotein-IB (GPIb) protects mice from ischemic stroke. To elucidate underlying mechanisms in-vivo, infarct development was followed by ultra-high field MRI at 17.6 Tesla. - METHODS: Cerebral infarction was induced by transient-midd...

Full description

Saved in:
Bibliographic Details
Main Authors: Pham, Mirko (Author) , Helluy, Xavier (Author) , Kleinschnitz, Christoph (Author) , Kraft, Peter (Author) , Bartsch, Andreas J. (Author) , Jakob, Peter (Author) , Nieswandt, Bernhard (Author) , Bendszus, Martin (Author) , Stoll, Guido (Author)
Format: Article (Journal)
Language:English
Published: April 1, 2011
In: PLOS ONE
Year: 2011, Volume: 6, Issue: 4, Pages: 1-8
ISSN:1932-6203
DOI:10.1371/journal.pone.0018386
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0018386
Get full text
Author Notes:Mirko Pham, Xavier Helluy, Christoph Kleinschnitz, Peter Kraft, Andreas J. Bartsch, Peter Jakob, Bernhard Nieswandt, Martin Bendszus, Guido Stoll
Description
Summary:BACKGROUND: Inhibition of early platelet adhesion by blockade of glycoprotein-IB (GPIb) protects mice from ischemic stroke. To elucidate underlying mechanisms in-vivo, infarct development was followed by ultra-high field MRI at 17.6 Tesla. - METHODS: Cerebral infarction was induced by transient-middle-cerebral-artery-occlusion (tMCAO) for 1 hour in C57/BL6 control mice (N=10) and mice treated with 100 µg Fab-fragments of the GPIb blocking antibody p0p/B 1 h after tMCAO (N=10). To control for the effect of reperfusion, additional mice underwent permanent occlusion and received anti-GPIb treatment (N=6; pMCAO) or remained without treatment (N=3; pMCAO). MRI 2 h and 24 h after MCAO measured cerebral-blood-flow (CBF) by continuous arterial-spin labelling, the apparent-diffusion-coefficient (ADC), quantitative-T2 and T2-weighted imaging. All images were registered to a standard mouse brain MRI atlas and statistically analysed voxel-wise, and by cortico-subcortical ROI analysis. - RESULTS: Anti-GPIb treatment led to a relative increase of postischemic CBF vs. controls in the cortical territory of the MCA (2 h: 44.2±6.9 ml/100 g/min versus 24 h: 60.5±8.4; p=0.0012, F((1,18))=14.63) after tMCAO. Subcortical CBF 2 h after tMCAO was higher in anti-GPIb treated animals (45.3±5.9 vs. controls: 33.6±4.3; p=0.04). In both regions, CBF findings were clearly related to a lower probability of infarction (Cortex/Subcortex of treated group: 35%/65% vs. controls: 95%/100%) and improved quantitative-T2 and ADC. After pMCAO, anti-GPIb treated mice developed similar infarcts preceded by severe irreversible hypoperfusion as controls after tMCAO indicating dependency of stroke protection on reperfusion. - CONCLUSION: Blockade of platelet adhesion by anti-GPIb-Fab-fragments results in substantially improved CBF early during reperfusion. This finding was in exact spatial correspondence with the prevention of cerebral infarction and indicates in-vivo an increased patency of the microcirculation. Thus, progression of infarction during early ischemia and reperfusion can be mitigated by anti-platelet treatment.
Item Description:Gesehen am 13.12.2022
Physical Description:Online Resource
ISSN:1932-6203
DOI:10.1371/journal.pone.0018386